Leading China-Based CRO Selects Instem's Provantis Portal for Remote Study Monitoring
7/19/2013 10:09:23 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
CONSHOHOCKEN, Pa.--(BUSINESS WIRE)--Instem, a leading provider of IT solutions to the global early development healthcare market, announced today that WuXi AppTec (WuXi), a leading supplier of R&D services to the pharmaceutical, biotechnology, and medical device industries with operations in China and the United States, has purchased the Provantis Portal™ Remote Study Monitoring solution. In 2009, WuXi selected Instem’s integrated Provantis preclinical solution suite to automate study processes at their newly constructed 314,000 square-feet toxicology facility in Suzhou. The Provantis Portal, launched in 2012, now allows WuXi’s toxicology clients to log into a secure Web site using any standard browser to view data from their on-going studies on-demand. This makes it easy for clients, particularly international organizations, to monitor their studies remotely while being able to more effectively communicate internally and with WuXi.
Help employers find you! Check out all the jobs and post your resume.